Skip to main navigation Skip to search Skip to main content

Streptozocin-diabetic rats show reduced hyperthermic effects but maintained anti-allodynia responses to the TRPV1 antagonist ABT-102 throughout nine days of dosing

Research output: Contribution to conference › Poster › peer-review

Fingerprint

Dive into the research topics of 'Streptozocin-diabetic rats show reduced hyperthermic effects but maintained anti-allodynia responses to the TRPV1 antagonist ABT-102 throughout nine days of dosing'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases